Biological skin consists of the outer epidermis and/or dermis (the layer of skin between the epidermis and subcutaneous tissue) embedded in an acellular matrix (supporting structure) to form a biological skin substitute. Products are made from a variety of sources, including human tissue (from patients or others), non-human tissue (bovine, porcine, horse), synthetic materials (man-made), or a combination of these materials.
The global Skin Substitutes from Biological Sources market size was valued at US$ 1767 million in 2023 and is forecast to a readjusted size of USD 3763 million by 2030 with a CAGR of 11.5% during review period.
This report is a detailed and comprehensive analysis for global Skin Substitutes from Biological Sources market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Skin Substitutes from Biological Sources market size and forecasts, in consumption value ($ Million), 2019-2030
Global Skin Substitutes from Biological Sources market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Skin Substitutes from Biological Sources market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Skin Substitutes from Biological Sources market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Skin Substitutes from Biological Sources
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Skin Substitutes from Biological Sources market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Allergan (AbbVie), AlloSource, Organogenesis, BD, Smith & Nephew, Integra LifeSciences, Synthes (Johnson & Johnson), Axogen, Vericel Corporation, LifeNet Health, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Skin Substitutes from Biological Sources market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segmentation
Skin Substitutes from Biological Sources market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Allogeneic Acellular Cells
Xenogeneic Cells
Allogeneic Cells
Autologous Cells
麻豆原创 segment by Application
Hospitals
Specialty Clinics
Wound Care Centers
麻豆原创 segment by players, this report covers
Allergan (AbbVie)
AlloSource
Organogenesis
BD
Smith & Nephew
Integra LifeSciences
Synthes (Johnson & Johnson)
Axogen
Vericel Corporation
LifeNet Health
MTF Biologics
Arthrex
Wright Medical Group NV (Stryker)
Cook Biotech Incorporated
Aroa Biosurgery
Surgalign Holdings
Anika Therapeutics
Forticell Bioscience
MLM Biologics
Promethean LifeSciences
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Skin Substitutes from Biological Sources product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Skin Substitutes from Biological Sources, with revenue, gross margin, and global market share of Skin Substitutes from Biological Sources from 2019 to 2024.
Chapter 3, the Skin Substitutes from Biological Sources competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Skin Substitutes from Biological Sources market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Skin Substitutes from Biological Sources.
Chapter 13, to describe Skin Substitutes from Biological Sources research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Skin Substitutes from Biological Sources by Type
1.3.1 Overview: Global Skin Substitutes from Biological Sources 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Skin Substitutes from Biological Sources Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Allogeneic Acellular Cells
1.3.4 Xenogeneic Cells
1.3.5 Allogeneic Cells
1.3.6 Autologous Cells
1.4 Global Skin Substitutes from Biological Sources 麻豆原创 by Application
1.4.1 Overview: Global Skin Substitutes from Biological Sources 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Specialty Clinics
1.4.4 Wound Care Centers
1.5 Global Skin Substitutes from Biological Sources 麻豆原创 Size & Forecast
1.6 Global Skin Substitutes from Biological Sources 麻豆原创 Size and Forecast by Region
1.6.1 Global Skin Substitutes from Biological Sources 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Skin Substitutes from Biological Sources 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Skin Substitutes from Biological Sources 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Skin Substitutes from Biological Sources 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Skin Substitutes from Biological Sources 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Skin Substitutes from Biological Sources 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East & Africa Skin Substitutes from Biological Sources 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 Allergan (AbbVie)
2.1.1 Allergan (AbbVie) Details
2.1.2 Allergan (AbbVie) Major Business
2.1.3 Allergan (AbbVie) Skin Substitutes from Biological Sources Product and Solutions
2.1.4 Allergan (AbbVie) Skin Substitutes from Biological Sources Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Allergan (AbbVie) Recent Developments and Future Plans
2.2 AlloSource
2.2.1 AlloSource Details
2.2.2 AlloSource Major Business
2.2.3 AlloSource Skin Substitutes from Biological Sources Product and Solutions
2.2.4 AlloSource Skin Substitutes from Biological Sources Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 AlloSource Recent Developments and Future Plans
2.3 Organogenesis
2.3.1 Organogenesis Details
2.3.2 Organogenesis Major Business
2.3.3 Organogenesis Skin Substitutes from Biological Sources Product and Solutions
2.3.4 Organogenesis Skin Substitutes from Biological Sources Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Organogenesis Recent Developments and Future Plans
2.4 BD
2.4.1 BD Details
2.4.2 BD Major Business
2.4.3 BD Skin Substitutes from Biological Sources Product and Solutions
2.4.4 BD Skin Substitutes from Biological Sources Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 BD Recent Developments and Future Plans
2.5 Smith & Nephew
2.5.1 Smith & Nephew Details
2.5.2 Smith & Nephew Major Business
2.5.3 Smith & Nephew Skin Substitutes from Biological Sources Product and Solutions
2.5.4 Smith & Nephew Skin Substitutes from Biological Sources Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Smith & Nephew Recent Developments and Future Plans
2.6 Integra LifeSciences
2.6.1 Integra LifeSciences Details
2.6.2 Integra LifeSciences Major Business
2.6.3 Integra LifeSciences Skin Substitutes from Biological Sources Product and Solutions
2.6.4 Integra LifeSciences Skin Substitutes from Biological Sources Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Integra LifeSciences Recent Developments and Future Plans
2.7 Synthes (Johnson & Johnson)
2.7.1 Synthes (Johnson & Johnson) Details
2.7.2 Synthes (Johnson & Johnson) Major Business
2.7.3 Synthes (Johnson & Johnson) Skin Substitutes from Biological Sources Product and Solutions
2.7.4 Synthes (Johnson & Johnson) Skin Substitutes from Biological Sources Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Synthes (Johnson & Johnson) Recent Developments and Future Plans
2.8 Axogen
2.8.1 Axogen Details
2.8.2 Axogen Major Business
2.8.3 Axogen Skin Substitutes from Biological Sources Product and Solutions
2.8.4 Axogen Skin Substitutes from Biological Sources Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Axogen Recent Developments and Future Plans
2.9 Vericel Corporation
2.9.1 Vericel Corporation Details
2.9.2 Vericel Corporation Major Business
2.9.3 Vericel Corporation Skin Substitutes from Biological Sources Product and Solutions
2.9.4 Vericel Corporation Skin Substitutes from Biological Sources Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Vericel Corporation Recent Developments and Future Plans
2.10 LifeNet Health
2.10.1 LifeNet Health Details
2.10.2 LifeNet Health Major Business
2.10.3 LifeNet Health Skin Substitutes from Biological Sources Product and Solutions
2.10.4 LifeNet Health Skin Substitutes from Biological Sources Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 LifeNet Health Recent Developments and Future Plans
2.11 MTF Biologics
2.11.1 MTF Biologics Details
2.11.2 MTF Biologics Major Business
2.11.3 MTF Biologics Skin Substitutes from Biological Sources Product and Solutions
2.11.4 MTF Biologics Skin Substitutes from Biological Sources Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 MTF Biologics Recent Developments and Future Plans
2.12 Arthrex
2.12.1 Arthrex Details
2.12.2 Arthrex Major Business
2.12.3 Arthrex Skin Substitutes from Biological Sources Product and Solutions
2.12.4 Arthrex Skin Substitutes from Biological Sources Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Arthrex Recent Developments and Future Plans
2.13 Wright Medical Group NV (Stryker)
2.13.1 Wright Medical Group NV (Stryker) Details
2.13.2 Wright Medical Group NV (Stryker) Major Business
2.13.3 Wright Medical Group NV (Stryker) Skin Substitutes from Biological Sources Product and Solutions
2.13.4 Wright Medical Group NV (Stryker) Skin Substitutes from Biological Sources Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 Wright Medical Group NV (Stryker) Recent Developments and Future Plans
2.14 Cook Biotech Incorporated
2.14.1 Cook Biotech Incorporated Details
2.14.2 Cook Biotech Incorporated Major Business
2.14.3 Cook Biotech Incorporated Skin Substitutes from Biological Sources Product and Solutions
2.14.4 Cook Biotech Incorporated Skin Substitutes from Biological Sources Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.14.5 Cook Biotech Incorporated Recent Developments and Future Plans
2.15 Aroa Biosurgery
2.15.1 Aroa Biosurgery Details
2.15.2 Aroa Biosurgery Major Business
2.15.3 Aroa Biosurgery Skin Substitutes from Biological Sources Product and Solutions
2.15.4 Aroa Biosurgery Skin Substitutes from Biological Sources Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.15.5 Aroa Biosurgery Recent Developments and Future Plans
2.16 Surgalign Holdings
2.16.1 Surgalign Holdings Details
2.16.2 Surgalign Holdings Major Business
2.16.3 Surgalign Holdings Skin Substitutes from Biological Sources Product and Solutions
2.16.4 Surgalign Holdings Skin Substitutes from Biological Sources Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.16.5 Surgalign Holdings Recent Developments and Future Plans
2.17 Anika Therapeutics
2.17.1 Anika Therapeutics Details
2.17.2 Anika Therapeutics Major Business
2.17.3 Anika Therapeutics Skin Substitutes from Biological Sources Product and Solutions
2.17.4 Anika Therapeutics Skin Substitutes from Biological Sources Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.17.5 Anika Therapeutics Recent Developments and Future Plans
2.18 Forticell Bioscience
2.18.1 Forticell Bioscience Details
2.18.2 Forticell Bioscience Major Business
2.18.3 Forticell Bioscience Skin Substitutes from Biological Sources Product and Solutions
2.18.4 Forticell Bioscience Skin Substitutes from Biological Sources Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.18.5 Forticell Bioscience Recent Developments and Future Plans
2.19 MLM Biologics
2.19.1 MLM Biologics Details
2.19.2 MLM Biologics Major Business
2.19.3 MLM Biologics Skin Substitutes from Biological Sources Product and Solutions
2.19.4 MLM Biologics Skin Substitutes from Biological Sources Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.19.5 MLM Biologics Recent Developments and Future Plans
2.20 Promethean LifeSciences
2.20.1 Promethean LifeSciences Details
2.20.2 Promethean LifeSciences Major Business
2.20.3 Promethean LifeSciences Skin Substitutes from Biological Sources Product and Solutions
2.20.4 Promethean LifeSciences Skin Substitutes from Biological Sources Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.20.5 Promethean LifeSciences Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Skin Substitutes from Biological Sources Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Skin Substitutes from Biological Sources by Company Revenue
3.2.2 Top 3 Skin Substitutes from Biological Sources Players 麻豆原创 Share in 2023
3.2.3 Top 6 Skin Substitutes from Biological Sources Players 麻豆原创 Share in 2023
3.3 Skin Substitutes from Biological Sources 麻豆原创: Overall Company Footprint Analysis
3.3.1 Skin Substitutes from Biological Sources 麻豆原创: Region Footprint
3.3.2 Skin Substitutes from Biological Sources 麻豆原创: Company Product Type Footprint
3.3.3 Skin Substitutes from Biological Sources 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Skin Substitutes from Biological Sources Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Skin Substitutes from Biological Sources 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Skin Substitutes from Biological Sources Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Skin Substitutes from Biological Sources 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Skin Substitutes from Biological Sources Consumption Value by Type (2019-2030)
6.2 North America Skin Substitutes from Biological Sources 麻豆原创 Size by Application (2019-2030)
6.3 North America Skin Substitutes from Biological Sources 麻豆原创 Size by Country
6.3.1 North America Skin Substitutes from Biological Sources Consumption Value by Country (2019-2030)
6.3.2 United States Skin Substitutes from Biological Sources 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Skin Substitutes from Biological Sources 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Skin Substitutes from Biological Sources 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Skin Substitutes from Biological Sources Consumption Value by Type (2019-2030)
7.2 Europe Skin Substitutes from Biological Sources Consumption Value by Application (2019-2030)
7.3 Europe Skin Substitutes from Biological Sources 麻豆原创 Size by Country
7.3.1 Europe Skin Substitutes from Biological Sources Consumption Value by Country (2019-2030)
7.3.2 Germany Skin Substitutes from Biological Sources 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Skin Substitutes from Biological Sources 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Skin Substitutes from Biological Sources 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Skin Substitutes from Biological Sources 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Skin Substitutes from Biological Sources 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Skin Substitutes from Biological Sources Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Skin Substitutes from Biological Sources Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Skin Substitutes from Biological Sources 麻豆原创 Size by Region
8.3.1 Asia-Pacific Skin Substitutes from Biological Sources Consumption Value by Region (2019-2030)
8.3.2 China Skin Substitutes from Biological Sources 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Skin Substitutes from Biological Sources 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Skin Substitutes from Biological Sources 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Skin Substitutes from Biological Sources 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Skin Substitutes from Biological Sources 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Skin Substitutes from Biological Sources 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Skin Substitutes from Biological Sources Consumption Value by Type (2019-2030)
9.2 South America Skin Substitutes from Biological Sources Consumption Value by Application (2019-2030)
9.3 South America Skin Substitutes from Biological Sources 麻豆原创 Size by Country
9.3.1 South America Skin Substitutes from Biological Sources Consumption Value by Country (2019-2030)
9.3.2 Brazil Skin Substitutes from Biological Sources 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Skin Substitutes from Biological Sources 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Skin Substitutes from Biological Sources Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Skin Substitutes from Biological Sources Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Skin Substitutes from Biological Sources 麻豆原创 Size by Country
10.3.1 Middle East & Africa Skin Substitutes from Biological Sources Consumption Value by Country (2019-2030)
10.3.2 Turkey Skin Substitutes from Biological Sources 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Skin Substitutes from Biological Sources 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Skin Substitutes from Biological Sources 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Skin Substitutes from Biological Sources 麻豆原创 Drivers
11.2 Skin Substitutes from Biological Sources 麻豆原创 Restraints
11.3 Skin Substitutes from Biological Sources Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Skin Substitutes from Biological Sources Industry Chain
12.2 Skin Substitutes from Biological Sources Upstream Analysis
12.3 Skin Substitutes from Biological Sources Midstream Analysis
12.4 Skin Substitutes from Biological Sources Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Allergan (AbbVie)
AlloSource
Organogenesis
BD
Smith & Nephew
Integra LifeSciences
Synthes (Johnson & Johnson)
Axogen
Vericel Corporation
LifeNet Health
MTF Biologics
Arthrex
Wright Medical Group NV (Stryker)
Cook Biotech Incorporated
Aroa Biosurgery
Surgalign Holdings
Anika Therapeutics
Forticell Bioscience
MLM Biologics
Promethean LifeSciences
听
听
*If Applicable.
